nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—DRD3—Parkinson's disease	0.19	0.249	CbGaD
Pramipexole—DRD1—Parkinson's disease	0.186	0.244	CbGaD
Pramipexole—HTR1A—Parkinson's disease	0.155	0.203	CbGaD
Pramipexole—DRD2—Parkinson's disease	0.131	0.172	CbGaD
Pramipexole—HTR2A—Parkinson's disease	0.101	0.133	CbGaD
Pramipexole—DRD3—telencephalic ventricle—Parkinson's disease	0.00436	0.052	CbGeAlD
Pramipexole—HTR2A—enteric nervous system—Parkinson's disease	0.00388	0.0463	CbGeAlD
Pramipexole—DRD1—telencephalic ventricle—Parkinson's disease	0.00312	0.0372	CbGeAlD
Pramipexole—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00294	0.0351	CbGeAlD
Pramipexole—HTR2A—locus ceruleus—Parkinson's disease	0.00256	0.0306	CbGeAlD
Pramipexole—HTR1B—telencephalic ventricle—Parkinson's disease	0.00253	0.0302	CbGeAlD
Pramipexole—HTR1D—telencephalic ventricle—Parkinson's disease	0.00245	0.0292	CbGeAlD
Pramipexole—HTR2C—telencephalic ventricle—Parkinson's disease	0.00242	0.0289	CbGeAlD
Pramipexole—HTR2A—cerebellar cortex—Parkinson's disease	0.00209	0.0249	CbGeAlD
Pramipexole—HTR1A—telencephalic ventricle—Parkinson's disease	0.00204	0.0243	CbGeAlD
Pramipexole—HTR2A—sympathetic nervous system—Parkinson's disease	0.00203	0.0242	CbGeAlD
Pramipexole—DRD1—nerve—Parkinson's disease	0.00197	0.0235	CbGeAlD
Pramipexole—DRD2—telencephalic ventricle—Parkinson's disease	0.00184	0.022	CbGeAlD
Pramipexole—HTR2A—pons—Parkinson's disease	0.00148	0.0176	CbGeAlD
Pramipexole—HTR2A—autonomic nervous system—Parkinson's disease	0.00136	0.0162	CbGeAlD
Pramipexole—HTR2A—telencephalic ventricle—Parkinson's disease	0.00122	0.0145	CbGeAlD
Pramipexole—DRD2—nerve—Parkinson's disease	0.00116	0.0139	CbGeAlD
Pramipexole—ADRA2A—peripheral nervous system—Parkinson's disease	0.00116	0.0138	CbGeAlD
Pramipexole—DRD5—forebrain—Parkinson's disease	0.00107	0.0127	CbGeAlD
Pramipexole—HTR2A—peripheral nervous system—Parkinson's disease	0.000983	0.0117	CbGeAlD
Pramipexole—HTR1A—hindbrain—Parkinson's disease	0.000963	0.0115	CbGeAlD
Pramipexole—DRD2—hindbrain—Parkinson's disease	0.00087	0.0104	CbGeAlD
Pramipexole—DRD1—brainstem—Parkinson's disease	0.000844	0.0101	CbGeAlD
Pramipexole—DRD1—forebrain—Parkinson's disease	0.000815	0.00972	CbGeAlD
Pramipexole—HTR2A—nerve—Parkinson's disease	0.000766	0.00914	CbGeAlD
Pramipexole—HTR1B—brainstem—Parkinson's disease	0.000684	0.00816	CbGeAlD
Pramipexole—DRD4—brain—Parkinson's disease	0.000672	0.00801	CbGeAlD
Pramipexole—HTR1D—brainstem—Parkinson's disease	0.000662	0.0079	CbGeAlD
Pramipexole—HTR1B—forebrain—Parkinson's disease	0.00066	0.00787	CbGeAlD
Pramipexole—HTR2C—brainstem—Parkinson's disease	0.000656	0.00782	CbGeAlD
Pramipexole—DRD3—head—Parkinson's disease	0.000651	0.00777	CbGeAlD
Pramipexole—SLC22A1—forebrain—Parkinson's disease	0.000645	0.00769	CbGeAlD
Pramipexole—HTR1D—forebrain—Parkinson's disease	0.000639	0.00762	CbGeAlD
Pramipexole—HTR2C—forebrain—Parkinson's disease	0.000633	0.00755	CbGeAlD
Pramipexole—DRD3—nervous system—Parkinson's disease	0.000618	0.00737	CbGeAlD
Pramipexole—DRD5—head—Parkinson's disease	0.000611	0.00728	CbGeAlD
Pramipexole—DRD3—central nervous system—Parkinson's disease	0.000595	0.00709	CbGeAlD
Pramipexole—HTR2B—forebrain—Parkinson's disease	0.000595	0.00709	CbGeAlD
Pramipexole—DRD5—nervous system—Parkinson's disease	0.000579	0.0069	CbGeAlD
Pramipexole—HTR2A—hindbrain—Parkinson's disease	0.000574	0.00685	CbGeAlD
Pramipexole—HTR1B—cardiovascular system—Parkinson's disease	0.000558	0.00666	CbGeAlD
Pramipexole—DRD5—central nervous system—Parkinson's disease	0.000557	0.00665	CbGeAlD
Pramipexole—HTR1A—brainstem—Parkinson's disease	0.000552	0.00658	CbGeAlD
Pramipexole—HTR1D—cardiovascular system—Parkinson's disease	0.00054	0.00645	CbGeAlD
Pramipexole—DRD1—midbrain—Parkinson's disease	0.000538	0.00642	CbGeAlD
Pramipexole—HTR1A—forebrain—Parkinson's disease	0.000533	0.00635	CbGeAlD
Pramipexole—HTR2B—cardiovascular system—Parkinson's disease	0.000503	0.006	CbGeAlD
Pramipexole—DRD2—brainstem—Parkinson's disease	0.000499	0.00595	CbGeAlD
Pramipexole—DRD2—forebrain—Parkinson's disease	0.000481	0.00574	CbGeAlD
Pramipexole—DRD3—brain—Parkinson's disease	0.000472	0.00563	CbGeAlD
Pramipexole—DRD1—head—Parkinson's disease	0.000466	0.00556	CbGeAlD
Pramipexole—HTR2C—medulla oblongata—Parkinson's disease	0.000457	0.00545	CbGeAlD
Pramipexole—HTR1A—cardiovascular system—Parkinson's disease	0.00045	0.00537	CbGeAlD
Pramipexole—DRD5—brain—Parkinson's disease	0.000442	0.00528	CbGeAlD
Pramipexole—DRD1—nervous system—Parkinson's disease	0.000442	0.00528	CbGeAlD
Pramipexole—HTR1B—midbrain—Parkinson's disease	0.000436	0.0052	CbGeAlD
Pramipexole—DRD1—central nervous system—Parkinson's disease	0.000426	0.00508	CbGeAlD
Pramipexole—HTR1B—spinal cord—Parkinson's disease	0.000425	0.00507	CbGeAlD
Pramipexole—HTR1D—midbrain—Parkinson's disease	0.000422	0.00503	CbGeAlD
Pramipexole—HTR2C—midbrain—Parkinson's disease	0.000418	0.00498	CbGeAlD
Pramipexole—HTR2C—spinal cord—Parkinson's disease	0.000408	0.00486	CbGeAlD
Pramipexole—HTR1B—head—Parkinson's disease	0.000378	0.00451	CbGeAlD
Pramipexole—ADRA2A—forebrain—Parkinson's disease	0.000373	0.00445	CbGeAlD
Pramipexole—SLC22A1—head—Parkinson's disease	0.000369	0.0044	CbGeAlD
Pramipexole—HTR1D—head—Parkinson's disease	0.000366	0.00436	CbGeAlD
Pramipexole—HTR2C—head—Parkinson's disease	0.000362	0.00432	CbGeAlD
Pramipexole—HTR2A—embryo—Parkinson's disease	0.000359	0.00428	CbGeAlD
Pramipexole—HTR1B—nervous system—Parkinson's disease	0.000358	0.00427	CbGeAlD
Pramipexole—HTR1A—midbrain—Parkinson's disease	0.000352	0.0042	CbGeAlD
Pramipexole—SLC22A1—nervous system—Parkinson's disease	0.00035	0.00418	CbGeAlD
Pramipexole—HTR1D—nervous system—Parkinson's disease	0.000347	0.00414	CbGeAlD
Pramipexole—HTR1B—central nervous system—Parkinson's disease	0.000345	0.00412	CbGeAlD
Pramipexole—HTR2C—nervous system—Parkinson's disease	0.000344	0.0041	CbGeAlD
Pramipexole—HTR1A—spinal cord—Parkinson's disease	0.000343	0.00409	CbGeAlD
Pramipexole—HTR2B—head—Parkinson's disease	0.00034	0.00406	CbGeAlD
Pramipexole—ADRA2C—medulla oblongata—Parkinson's disease	0.000338	0.00403	CbGeAlD
Pramipexole—DRD1—brain—Parkinson's disease	0.000338	0.00403	CbGeAlD
Pramipexole—SLC22A1—central nervous system—Parkinson's disease	0.000337	0.00402	CbGeAlD
Pramipexole—HTR1D—central nervous system—Parkinson's disease	0.000334	0.00398	CbGeAlD
Pramipexole—HTR2C—central nervous system—Parkinson's disease	0.000331	0.00395	CbGeAlD
Pramipexole—HTR2A—brainstem—Parkinson's disease	0.000329	0.00392	CbGeAlD
Pramipexole—HTR2B—nervous system—Parkinson's disease	0.000323	0.00385	CbGeAlD
Pramipexole—DRD2—midbrain—Parkinson's disease	0.000318	0.00379	CbGeAlD
Pramipexole—HTR2A—forebrain—Parkinson's disease	0.000317	0.00379	CbGeAlD
Pramipexole—HTR2B—central nervous system—Parkinson's disease	0.000311	0.00371	CbGeAlD
Pramipexole—ADRA2C—midbrain—Parkinson's disease	0.000309	0.00369	CbGeAlD
Pramipexole—HTR1A—head—Parkinson's disease	0.000305	0.00364	CbGeAlD
Pramipexole—ADRA2C—spinal cord—Parkinson's disease	0.000301	0.0036	CbGeAlD
Pramipexole—HTR1A—nervous system—Parkinson's disease	0.000289	0.00345	CbGeAlD
Pramipexole—HTR1A—central nervous system—Parkinson's disease	0.000278	0.00332	CbGeAlD
Pramipexole—DRD2—head—Parkinson's disease	0.000276	0.00329	CbGeAlD
Pramipexole—HTR1B—brain—Parkinson's disease	0.000274	0.00327	CbGeAlD
Pramipexole—HTR1A—cerebellum—Parkinson's disease	0.000272	0.00325	CbGeAlD
Pramipexole—ADRA2A—medulla oblongata—Parkinson's disease	0.00027	0.00322	CbGeAlD
Pramipexole—HTR2A—cardiovascular system—Parkinson's disease	0.000268	0.0032	CbGeAlD
Pramipexole—ADRA2C—head—Parkinson's disease	0.000268	0.0032	CbGeAlD
Pramipexole—SLC22A1—brain—Parkinson's disease	0.000268	0.00319	CbGeAlD
Pramipexole—HTR1D—brain—Parkinson's disease	0.000265	0.00316	CbGeAlD
Pramipexole—HTR2C—brain—Parkinson's disease	0.000263	0.00313	CbGeAlD
Pramipexole—DRD2—nervous system—Parkinson's disease	0.000261	0.00312	CbGeAlD
Pramipexole—ADRA2C—nervous system—Parkinson's disease	0.000254	0.00303	CbGeAlD
Pramipexole—DRD2—central nervous system—Parkinson's disease	0.000252	0.003	CbGeAlD
Pramipexole—HTR2B—brain—Parkinson's disease	0.000247	0.00294	CbGeAlD
Pramipexole—ADRA2A—midbrain—Parkinson's disease	0.000247	0.00294	CbGeAlD
Pramipexole—DRD2—cerebellum—Parkinson's disease	0.000246	0.00293	CbGeAlD
Pramipexole—ADRA2C—central nervous system—Parkinson's disease	0.000245	0.00292	CbGeAlD
Pramipexole—ADRA2A—spinal cord—Parkinson's disease	0.000241	0.00287	CbGeAlD
Pramipexole—ADRA2C—cerebellum—Parkinson's disease	0.000239	0.00285	CbGeAlD
Pramipexole—HTR2A—medulla oblongata—Parkinson's disease	0.000229	0.00274	CbGeAlD
Pramipexole—HTR1A—brain—Parkinson's disease	0.000221	0.00264	CbGeAlD
Pramipexole—ADRA2A—head—Parkinson's disease	0.000214	0.00255	CbGeAlD
Pramipexole—HTR2A—midbrain—Parkinson's disease	0.00021	0.0025	CbGeAlD
Pramipexole—HTR2A—spinal cord—Parkinson's disease	0.000205	0.00244	CbGeAlD
Pramipexole—ADRA2A—nervous system—Parkinson's disease	0.000203	0.00242	CbGeAlD
Pramipexole—DRD2—brain—Parkinson's disease	0.0002	0.00238	CbGeAlD
Pramipexole—ADRA2A—central nervous system—Parkinson's disease	0.000195	0.00233	CbGeAlD
Pramipexole—ADRA2C—brain—Parkinson's disease	0.000194	0.00232	CbGeAlD
Pramipexole—ADRA2A—cerebellum—Parkinson's disease	0.000191	0.00228	CbGeAlD
Pramipexole—HTR2A—head—Parkinson's disease	0.000182	0.00217	CbGeAlD
Pramipexole—HTR2A—nervous system—Parkinson's disease	0.000172	0.00206	CbGeAlD
Pramipexole—HTR2A—central nervous system—Parkinson's disease	0.000166	0.00198	CbGeAlD
Pramipexole—HTR2A—cerebellum—Parkinson's disease	0.000162	0.00193	CbGeAlD
Pramipexole—ADRA2A—brain—Parkinson's disease	0.000155	0.00185	CbGeAlD
Pramipexole—HTR2A—brain—Parkinson's disease	0.000132	0.00157	CbGeAlD
Pramipexole—SLC22A1—Metabolism—NQO1—Parkinson's disease	9.64e-06	6.28e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HTR1A—Parkinson's disease	9.63e-06	6.28e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	9.61e-06	6.26e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—APOE—Parkinson's disease	9.6e-06	6.25e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	9.56e-06	6.23e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CYCS—Parkinson's disease	9.52e-06	6.2e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—TH—Parkinson's disease	9.5e-06	6.19e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TAC1—Parkinson's disease	9.49e-06	6.18e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IGF2—Parkinson's disease	9.46e-06	6.16e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	9.31e-06	6.07e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD1—Parkinson's disease	9.3e-06	6.06e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FGF20—Parkinson's disease	9.3e-06	6.06e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—INSR—Parkinson's disease	9.3e-06	6.06e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	9.26e-06	6.04e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IGF2—Parkinson's disease	9.26e-06	6.04e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—INSR—Parkinson's disease	9.15e-06	5.96e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IGF1R—Parkinson's disease	9.15e-06	5.96e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CYCS—Parkinson's disease	9.12e-06	5.95e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IGF2—Parkinson's disease	9.12e-06	5.94e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EDN1—Parkinson's disease	9.04e-06	5.89e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CYP2D6—Parkinson's disease	9.04e-06	5.89e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ADORA2A—Parkinson's disease	9.02e-06	5.88e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD3—Parkinson's disease	9.01e-06	5.87e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ADRBK1—Parkinson's disease	9.01e-06	5.87e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—EDN1—Parkinson's disease	8.97e-06	5.85e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	8.96e-06	5.84e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CTGF—Parkinson's disease	8.87e-06	5.78e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	8.85e-06	5.77e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IGF1R—Parkinson's disease	8.81e-06	5.74e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—FGB—Parkinson's disease	8.79e-06	5.73e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	8.77e-06	5.71e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	8.74e-06	5.7e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HTR7—Parkinson's disease	8.72e-06	5.68e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DRD2—Parkinson's disease	8.72e-06	5.68e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EDN1—Parkinson's disease	8.71e-06	5.67e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	8.7e-06	5.67e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	8.69e-06	5.67e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—COMT—Parkinson's disease	8.67e-06	5.65e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	8.65e-06	5.64e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—FGB—Parkinson's disease	8.64e-06	5.63e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	8.64e-06	5.63e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GSTP1—Parkinson's disease	8.63e-06	5.62e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—MAOA—Parkinson's disease	8.61e-06	5.61e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TAC1—Parkinson's disease	8.61e-06	5.61e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	8.6e-06	5.6e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—HMOX1—Parkinson's disease	8.51e-06	5.54e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	8.47e-06	5.52e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—DRD1—Parkinson's disease	8.44e-06	5.5e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—COMT—Parkinson's disease	8.43e-06	5.49e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	8.42e-06	5.49e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	8.42e-06	5.49e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ADRBK1—Parkinson's disease	8.41e-06	5.48e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	8.41e-06	5.48e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GSTP1—Parkinson's disease	8.39e-06	5.47e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	8.38e-06	5.46e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	8.38e-06	5.46e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—MAOA—Parkinson's disease	8.37e-06	5.46e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	8.32e-06	5.42e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	8.31e-06	5.42e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NGF—Parkinson's disease	8.31e-06	5.41e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	8.31e-06	5.41e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—HMOX1—Parkinson's disease	8.28e-06	5.39e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	8.26e-06	5.39e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IGF2—Parkinson's disease	8.21e-06	5.35e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—INS—Parkinson's disease	8.2e-06	5.34e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—DRD3—Parkinson's disease	8.17e-06	5.33e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—NQO1—Parkinson's disease	8.17e-06	5.33e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ABCB1—Parkinson's disease	8.17e-06	5.32e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD2—Parkinson's disease	8.15e-06	5.31e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HTR7—Parkinson's disease	8.15e-06	5.31e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NGF—Parkinson's disease	8.13e-06	5.3e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IGF2—Parkinson's disease	8.1e-06	5.28e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—COMT—Parkinson's disease	8.08e-06	5.27e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—TH—Parkinson's disease	8.05e-06	5.25e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	8.04e-06	5.24e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GSTP1—Parkinson's disease	8.04e-06	5.24e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—MAOA—Parkinson's disease	8.02e-06	5.23e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NGF—Parkinson's disease	8e-06	5.21e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ABCB1—Parkinson's disease	7.94e-06	5.18e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	7.93e-06	5.17e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—HMOX1—Parkinson's disease	7.93e-06	5.17e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GSTM1—Parkinson's disease	7.93e-06	5.17e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	7.91e-06	5.15e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	7.86e-06	5.13e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	7.85e-06	5.11e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EDN1—Parkinson's disease	7.84e-06	5.11e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	7.83e-06	5.1e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	7.82e-06	5.1e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	7.74e-06	5.04e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EDN1—Parkinson's disease	7.74e-06	5.04e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CYCS—Parkinson's disease	7.73e-06	5.04e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GSTM1—Parkinson's disease	7.71e-06	5.03e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	7.7e-06	5.02e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NGF—Parkinson's disease	7.64e-06	4.98e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	7.63e-06	4.97e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HTR2A—Parkinson's disease	7.62e-06	4.96e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ABCB1—Parkinson's disease	7.61e-06	4.96e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GPX1—Parkinson's disease	7.59e-06	4.95e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	7.56e-06	4.92e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	7.51e-06	4.89e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR7—Parkinson's disease	7.39e-06	4.82e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GSTM1—Parkinson's disease	7.39e-06	4.82e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GPX1—Parkinson's disease	7.38e-06	4.81e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—APOE—Parkinson's disease	7.35e-06	4.79e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	7.32e-06	4.77e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	7.31e-06	4.76e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	7.27e-06	4.74e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	7.27e-06	4.74e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	7.27e-06	4.74e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NGF—Parkinson's disease	7.2e-06	4.69e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—APOE—Parkinson's disease	7.2e-06	4.69e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NGF—Parkinson's disease	7.11e-06	4.63e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—APOE—Parkinson's disease	7.08e-06	4.62e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GPX1—Parkinson's disease	7.08e-06	4.61e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	7.07e-06	4.61e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	7.06e-06	4.6e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	7.02e-06	4.57e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—MTHFR—Parkinson's disease	7.01e-06	4.57e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	6.98e-06	4.55e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	6.86e-06	4.47e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—COMT—Parkinson's disease	6.85e-06	4.46e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	6.83e-06	4.45e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	6.83e-06	4.45e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	6.82e-06	4.45e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GSTP1—Parkinson's disease	6.82e-06	4.44e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—MTHFR—Parkinson's disease	6.82e-06	4.44e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—MAOA—Parkinson's disease	6.8e-06	4.43e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	6.79e-06	4.42e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	6.77e-06	4.41e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—APOE—Parkinson's disease	6.76e-06	4.41e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	6.74e-06	4.39e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—HMOX1—Parkinson's disease	6.72e-06	4.38e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	6.71e-06	4.37e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	6.62e-06	4.31e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	6.62e-06	4.31e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	6.6e-06	4.3e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—MTHFR—Parkinson's disease	6.53e-06	4.26e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	6.52e-06	4.25e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—APOE—Parkinson's disease	6.52e-06	4.25e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ABCB1—Parkinson's disease	6.45e-06	4.2e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	6.42e-06	4.18e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—APOE—Parkinson's disease	6.38e-06	4.15e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—APOE—Parkinson's disease	6.34e-06	4.13e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—APOE—Parkinson's disease	6.29e-06	4.1e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—INS—Parkinson's disease	6.28e-06	4.09e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GSTM1—Parkinson's disease	6.26e-06	4.08e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF2—Parkinson's disease	6.2e-06	4.04e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NGF—Parkinson's disease	6.2e-06	4.04e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NGF—Parkinson's disease	6.16e-06	4.02e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—INS—Parkinson's disease	6.15e-06	4.01e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	6.11e-06	3.98e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CASP3—Parkinson's disease	6.1e-06	3.98e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	6.1e-06	3.97e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—APOE—Parkinson's disease	6.08e-06	3.96e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—IL6—Parkinson's disease	6.06e-06	3.95e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—INS—Parkinson's disease	6.05e-06	3.94e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GPX1—Parkinson's disease	6e-06	3.91e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	5.99e-06	3.91e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	5.99e-06	3.9e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EDN1—Parkinson's disease	5.92e-06	3.86e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	5.9e-06	3.84e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	5.89e-06	3.84e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	5.87e-06	3.82e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	5.82e-06	3.8e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—INS—Parkinson's disease	5.78e-06	3.76e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	5.71e-06	3.72e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	5.68e-06	3.7e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MAPK8—Parkinson's disease	5.61e-06	3.66e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—INS—Parkinson's disease	5.57e-06	3.63e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	5.55e-06	3.61e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—MTHFR—Parkinson's disease	5.54e-06	3.61e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—APOE—Parkinson's disease	5.48e-06	3.57e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—APOE—Parkinson's disease	5.45e-06	3.55e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—INS—Parkinson's disease	5.45e-06	3.55e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NGF—Parkinson's disease	5.44e-06	3.54e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—INS—Parkinson's disease	5.42e-06	3.53e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—INS—Parkinson's disease	5.37e-06	3.5e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	5.36e-06	3.49e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NGF—Parkinson's disease	5.35e-06	3.49e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	5.31e-06	3.46e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	5.3e-06	3.45e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—INS—Parkinson's disease	5.19e-06	3.38e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	5.18e-06	3.37e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—APOE—Parkinson's disease	5.15e-06	3.36e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	4.87e-06	3.17e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—INS—Parkinson's disease	4.85e-06	3.16e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—APOE—Parkinson's disease	4.81e-06	3.14e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—APOE—Parkinson's disease	4.74e-06	3.09e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—INS—Parkinson's disease	4.68e-06	3.05e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	4.68e-06	3.05e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—INS—Parkinson's disease	4.66e-06	3.04e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	4.64e-06	3.03e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	4.64e-06	3.02e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	4.58e-06	2.98e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	4.55e-06	2.96e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—INS—Parkinson's disease	4.53e-06	2.95e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CASP3—Parkinson's disease	4.5e-06	2.94e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL6—Parkinson's disease	4.48e-06	2.92e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—INS—Parkinson's disease	4.4e-06	2.87e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	4.31e-06	2.81e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	4.3e-06	2.8e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	4.3e-06	2.8e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	4.27e-06	2.78e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	4.21e-06	2.74e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	4.14e-06	2.7e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—INS—Parkinson's disease	4.11e-06	2.68e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CASP3—Parkinson's disease	4.06e-06	2.64e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—INS—Parkinson's disease	4.05e-06	2.64e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—Parkinson's disease	4.03e-06	2.63e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CASP3—Parkinson's disease	4e-06	2.61e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—Parkinson's disease	3.98e-06	2.59e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	3.95e-06	2.58e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	3.73e-06	2.43e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—INS—Parkinson's disease	3.68e-06	2.4e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	3.68e-06	2.4e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	3.61e-06	2.35e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	3.59e-06	2.34e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—Parkinson's disease	3.58e-06	2.33e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	3.49e-06	2.27e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	3.47e-06	2.26e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	3.46e-06	2.26e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	3.45e-06	2.25e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	3.37e-06	2.2e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	3.35e-06	2.18e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	3.32e-06	2.16e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	3.2e-06	2.09e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	3.19e-06	2.08e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	3.1e-06	2.02e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CASP3—Parkinson's disease	3.06e-06	2e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—Parkinson's disease	3.04e-06	1.98e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	3.01e-06	1.96e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.99e-06	1.95e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.81e-06	1.83e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.77e-06	1.8e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—Parkinson's disease	2.74e-06	1.79e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	2.74e-06	1.79e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	2.72e-06	1.77e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—Parkinson's disease	2.69e-06	1.75e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—Parkinson's disease	2.64e-06	1.72e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—Parkinson's disease	2.52e-06	1.64e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	2.52e-06	1.64e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—Parkinson's disease	2.38e-06	1.55e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—Parkinson's disease	2.35e-06	1.53e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	2.12e-06	1.38e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—Parkinson's disease	2.05e-06	1.33e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.04e-06	1.33e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	1.98e-06	1.29e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.8e-06	1.17e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.77e-06	1.15e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.61e-06	1.05e-05	CbGpPWpGaD
